相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platelet-derived growth factor signaling through ephrin-B2 regulates hepatic vascular structure and function
David Semela et al.
GASTROENTEROLOGY (2008)
The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats
Marc Mejias et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats
Hao Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
How to prevent varices from bleeding:: Shades of grey -: The case for nonselective β blockers
Ulrich Thalheimer et al.
GASTROENTEROLOGY (2007)
Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts
Atsushi Tanaka et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats
Mercedes Fernandez et al.
HEPATOLOGY (2007)
NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats
Bernhard Angermayr et al.
GUT (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sinusoidal remodeling and angiogenesis: A new function for the liver-specific pericyte?
June Sung Lee et al.
HEPATOLOGY (2007)
Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis
Markus Neef et al.
JOURNAL OF HEPATOLOGY (2006)
Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: A systematic review
Gennaro D'Amico et al.
GASTROENTEROLOGY (2006)
Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats
Bernhard Angermayr et al.
JOURNAL OF HEPATOLOGY (2006)
Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats
M Fernandez et al.
JOURNAL OF HEPATOLOGY (2005)
Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis:: Analysis of the underlying mechanisms
E Biecker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice
M Fernandez et al.
GASTROENTEROLOGY (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites
A Albillos et al.
LANCET (2004)
Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis
J Medina et al.
JOURNAL OF HEPATOLOGY (2003)
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis
JG Abraldes et al.
HEPATOLOGY (2003)
The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
R Wiest et al.
HEPATOLOGY (2002)
分享论文
